Physiotherapy Treatment for Gynecological Cancer Survivors With Urinary Incontinence
Pilot Study Examining Feasibility and Effects of Physiotherapy Treatment Compared to Standard Usual Care in Gynecological Cancer Survivors With Urinary Incontinence
1 other identifier
interventional
44
1 country
1
Brief Summary
The aims of this pilot study are to examine the feasibility and to explore the effects of a physiotherapy treatment compared to standard usual care in gynecological cancer survivors with urinary incontinence in preparation of a large randomized controlled study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2018
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 16, 2018
CompletedFirst Submitted
Initial submission to the registry
April 10, 2019
CompletedFirst Posted
Study publicly available on registry
May 21, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 16, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
October 16, 2025
CompletedFebruary 24, 2025
February 1, 2025
7 years
April 10, 2019
February 20, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Adherence rates
To determine acceptability by assessing adherence to exercises.
Baseline to 2-week post-treatment evaluation
Retention rate
To determine feasibility by evaluating attrition.
Baseline to 2-week post-treatment evaluation
Secondary Outcomes (8)
Change from baseline in number of urinary leaks
Baseline to 2-week post-treatment
Change from baseline in symptoms of pelvic floor dysfunction
Baseline to 2-week post-treatment evaluation
Change from baseline in pelvic floor muscle function
Baseline to 2-week post-treatment evaluation
Change from baseline in pelvic floor muscle morphometry
Baseline to 2-week post-treatment evaluation
Change from baseline in sexual function
Baseline to 2-week post-treatment evaluation
- +3 more secondary outcomes
Study Arms (2)
Physiotherapy
EXPERIMENTAL12-weekly physiotherapy treatment sessions.
Standard usual care
NO INTERVENTIONParticipants will be asked to continue the usual care established during the regular follow-up with their medical doctor for 12 weeks.
Interventions
Education, pelvic floor muscle exercises with biofeedback and home exercises.
Eligibility Criteria
You may qualify if:
- History of gynecological cancer (endometrial, cervical, vaginal or other parts of the uterus)
- Scheduled oncological treatments completed
- Stress or mixed urinary incontinence with a frequency of at least three urinary leakage per
You may not qualify if:
- Pelvic floor rehabilitation in the last year
- Other conditions interfering with assessment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Centre de Recherche du Centre Hospitalier Universitaire de Sherbrooke
Sherbrooke, Quebec, J1H 5N4, Canada
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Researcher and Associate Professor
Study Record Dates
First Submitted
April 10, 2019
First Posted
May 21, 2019
Study Start
October 16, 2018
Primary Completion
October 16, 2025
Study Completion
October 16, 2025
Last Updated
February 24, 2025
Record last verified: 2025-02